Related Experiment Video

Updated: May 1, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

10.3K

Interleukin-30: A novel microenvironmental hallmark of prostate cancer progression

Emma Di Carlo1

  • 1Department of Medicine and Sciences of Aging; Section of Anatomic Pathology and Molecular Medicine; "G. d'Annunzio" University Foundation; Chieti, Italy ; Ce.S.I. Biotech; Aging Research Center; "G. d'Annunzio" University Foundation; Chieti, Italy.

Oncoimmunology
|April 18, 2014
PubMed

Insights

Interleukin-30 (IL-30) promotes prostate cancer growth and spread by altering the tumor microenvironment. Targeting IL-30 may offer new therapeutic strategies for advanced prostate cancer.

Area of Science:

  • Oncology
  • Immunology

Background:

  • Metastatic prostate cancer is a significant cause of cancer mortality in men globally.
  • The tumor microenvironment plays a critical role in cancer progression.

Purpose of the Study:

  • To investigate the role of Interleukin-30 (IL-30) in the progression of prostate cancer.
  • To determine if IL-30 is a potential therapeutic target for prostate cancer.

Main Methods:

  • In vitro studies assessing IL-30's effect on tumor growth.
  • Analysis of IL-30 expression in prostate cancer patient samples.

Main Results:

  • IL-30 was found to support prostate cancer growth in vitro.
  • Elevated IL-30 expression correlated with higher tumor grade and metastatic stage in patients.

Conclusions:

  • IL-30 influences the tumor microenvironment to promote prostate cancer progression.
  • IL-30 represents a promising therapeutic target for inhibiting prostate cancer advancement.
Keywords:
IL-27p28IL-30lymph node metastasisprostate cancer progressiontumor microenvironmenttumor-infiltrating leukocytes

More Related Videos

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

5.8K
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

915

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

2.7K